{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.035B vs. cons $1.020B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.91 vs. cons $0.88",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "HOKA revenue",
      "prediction": "BEAT",
      "answer": "pred ~$712M vs. cons $704M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q2 revenue",
      "prediction": "BETTER",
      "answer": "guide ~$1.55B vs. cons $1.52B (2027Q2)",
      "confidence": "LOW"
    },
    {
      "kpi": "Q2 diluted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$1.91 vs. cons $1.87 (2027Q2)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 HOKA growth",
      "prediction": "BETTER",
      "answer": "guide ~11% vs. cons 10% (2027Q2)",
      "confidence": "LOW"
    },
    {
      "kpi": "Full-year diluted EPS",
      "prediction": "LOWER",
      "answer": "guide midpoint ~$7.38 vs. cons $7.46 (FY2027)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 6.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.0,
  "day5_path": "FADE",
  "day5_rationale": "The initial reaction rewards the Q1 beat and Q2 HOKA acceleration, but the 5-day residual fades to +4.0% from +6.5% on day 1 because unchanged FY2027 guidance remains below consensus and limits upward estimate revisions.",
  "day5_confidence": "MEDIUM"
}